Correlation Between VTv Therapeutics and Standard Biotools

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VTv Therapeutics and Standard Biotools at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTv Therapeutics and Standard Biotools into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between vTv Therapeutics and Standard Biotools, you can compare the effects of market volatilities on VTv Therapeutics and Standard Biotools and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTv Therapeutics with a short position of Standard Biotools. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTv Therapeutics and Standard Biotools.

Diversification Opportunities for VTv Therapeutics and Standard Biotools

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between VTv and Standard is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and Standard Biotools in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Biotools and VTv Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on vTv Therapeutics are associated (or correlated) with Standard Biotools. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Biotools has no effect on the direction of VTv Therapeutics i.e., VTv Therapeutics and Standard Biotools go up and down completely randomly.

Pair Corralation between VTv Therapeutics and Standard Biotools

Given the investment horizon of 90 days vTv Therapeutics is expected to generate 1.44 times more return on investment than Standard Biotools. However, VTv Therapeutics is 1.44 times more volatile than Standard Biotools. It trades about 0.07 of its potential returns per unit of risk. Standard Biotools is currently generating about -0.1 per unit of risk. If you would invest  1,397  in vTv Therapeutics on December 28, 2024 and sell it today you would earn a total of  318.00  from holding vTv Therapeutics or generate 22.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.36%
ValuesDaily Returns

vTv Therapeutics  vs.  Standard Biotools

 Performance 
       Timeline  
vTv Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, VTv Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Standard Biotools 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Standard Biotools has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

VTv Therapeutics and Standard Biotools Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VTv Therapeutics and Standard Biotools

The main advantage of trading using opposite VTv Therapeutics and Standard Biotools positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTv Therapeutics position performs unexpectedly, Standard Biotools can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Biotools will offset losses from the drop in Standard Biotools' long position.
The idea behind vTv Therapeutics and Standard Biotools pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges